Agilent Technologies, Inc. $A Shares Acquired by Nordea Investment Management AB

Nordea Investment Management AB increased its position in Agilent Technologies, Inc. (NYSE:A) by 16.2% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,213,748 shares of the medical research company’s stock after purchasing an additional 447,207 shares during the period. Nordea Investment Management AB’s holdings in Agilent Technologies were worth $383,143,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Werba Rubin Papier Wealth Management grew its stake in Agilent Technologies by 42.0% in the second quarter. Werba Rubin Papier Wealth Management now owns 4,185 shares of the medical research company’s stock worth $494,000 after purchasing an additional 1,237 shares in the last quarter. Allianz Asset Management GmbH lifted its holdings in Agilent Technologies by 26.5% in the second quarter. Allianz Asset Management GmbH now owns 945,889 shares of the medical research company’s stock worth $111,624,000 after acquiring an additional 198,195 shares during the last quarter. Mutual Advisors LLC lifted its holdings in Agilent Technologies by 7.3% in the second quarter. Mutual Advisors LLC now owns 7,701 shares of the medical research company’s stock worth $925,000 after acquiring an additional 522 shares during the last quarter. Sagespring Wealth Partners LLC bought a new position in Agilent Technologies in the second quarter worth about $277,000. Finally, NorthRock Partners LLC lifted its holdings in Agilent Technologies by 64.6% in the second quarter. NorthRock Partners LLC now owns 4,953 shares of the medical research company’s stock worth $585,000 after acquiring an additional 1,944 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. UBS Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and raised their target price for the stock from $130.00 to $170.00 in a report on Wednesday, October 8th. Barclays raised their target price on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a report on Thursday, October 2nd. Robert W. Baird raised their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a report on Thursday, August 28th. Wells Fargo & Company raised their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, September 15th. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $141.14 on Friday. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The stock has a market cap of $40.01 billion, a price-to-earnings ratio of 33.13, a PEG ratio of 4.56 and a beta of 1.26. The stock’s 50 day moving average price is $127.03 and its 200 day moving average price is $117.63. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the company earned $1.32 earnings per share. The firm’s quarterly revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be issued a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s payout ratio is presently 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.